US2005118281A1PendingUtilityA1

Ionic silver complex

Priority: Nov 9, 1998Filed: Jan 4, 2005Published: Jun 2, 2005
Est. expiryNov 9, 2018(expired)· nominal 20-yr term from priority
A61P 31/04A61P 31/12A61P 27/02A61P 31/16A61P 31/10A61K 47/12A61K 9/0048A61K 9/08A61K 47/18A61K 33/38Y10S424/13A61K 9/0095A61K 9/0034A61P 17/10Y10S424/06A01N 59/16A61P 1/02A61K 9/0056A61K 9/0014
49
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention relates to a substantially non-colloidal solution comprising (a) water; (b) silver ions; and (c) a substantially non-toxic, substantially thiol-free, substantially water-soluble complexing agent.

Claims

exact text as granted — not AI-modified
1 . A substantially non-colloidal solution made by combining ingredients comprising: (a) water; (b) a source of free silver ions; and (c) a substantially non-toxic, substantially thiol-free, substantially water-soluble complexing agent.  
     
     
         2 . The substantially non-colloidal solution of  claim 1 , wherein the non-colloidal solution possesses less than about ten weight percent of free silver based on the weight of total silver.  
     
     
         3 . The substantially non-colloidal solution of  claim 2 , wherein the non-colloidal solution possesses less than about one weight percent of free silver based the weight of total silver.  
     
     
         4 . The substantially non-colloidal solution of  claim 3 , wherein the non-colloidal solution possesses less than about one-tenth of a percent by weight of free silver based on the weight of total silver.  
     
     
         5 . The substantially non-colloidal solution of  claim 1 , wherein the non-colloidal solution possesses greater than about twenty parts of total silver per million parts of the non-colloidal solution.  
     
     
         6 . The substantially non-colloidal solution of  claim 5 , wherein the non-colloidal solution possesses greater than about fifty parts of total silver per million parts of the non-colloidal solution.  
     
     
         7 . The substantially non-colloidal solution of  claim 6 , wherein the non-colloidal solution possesses greater than or equal to about one hundred parts of total silver per million parts of the non-colloidal solution.  
     
     
         8 . The substantially non-colloidal solution of  claim 1 , wherein the source of free silver ions comprises silver oxide, trisilver citrate, or silver acetate.  
     
     
         9 . The substantially non-colloidal solution of  claim 8 , wherein the source of free silver ions comprises silver oxide.  
     
     
         10 . The substantially non-colloidal solution of  claim 1 , wherein the substantially non-toxic, substantially thiol-free, substantially water-soluble complexing agent comprises a carboxylic acid, or a primary, secondary or tertiary amine.  
     
     
         11 . The substantially non-colloidal solution of  claim 10 , wherein the substantially non-toxic, substantially thiol-free, substantially water-soluble complexing agent comprises amino acids or hydroxy acids.  
     
     
         12 . The substantially non-colloidal solution of  claim 11 , wherein the amino acids comprise glycine, alanine, valine, leucine, isoleucine, methionine, proline, phenylalanine, tryptophan, serine, threonine, tyrosine, asparagine, glutamine, aspartic acid, glutamic acid, lysine, arginine, or histidine.  
     
     
         13 . The substantially non-colloidal solution of  claim 12 , wherein the hydroxy acids comprise glycolic acid, lactic acid, malic acid, tartaric acid, citric acid, or mandelic acid.  
     
     
         14 . The substantially non-colloidal solution of  claim 13;  wherein the citric acid is dibasic citrate.  
     
     
         15 . The substantially non-colloidal solution of  claim 1 , wherein the free silver ions are present in the substantially non-colloidal solution in an anti-microbially effective amount.  
     
     
         16 . The substantially non-colloidal solution of  claim 1 , wherein the ingredients further comprise a source of counter-ions.  
     
     
         17 . The substantially non-colloidal solution of  claim 1 , wherein the source of counter-ions comprises potassium ions, or calcium ions.

Join the waitlist — get patent alerts

Track US2005118281A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.